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decision making problems, public domain software pack- 
ages for both data-driven and subjective estimation of 
probability densities from the Johnson translation system of 
distributions have also been developed. For the analysis of 
complex problems that cannot be adequately represented 
by probability trees or by simple stochastic processes such 
as Markov chains, network simulation approaches that are 
oriented toward the sequence of activities seen by individual 
patients in the course of treatment are described. 
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Effective handling of uncertainty is one of the central 
problems in medical decision making. The sources and 
effects of uncertainty in medical decision making are exam- 
ined and some new quantitative approaches for solving the 
associated problems are outlined. To handle uncertainty in 
the branching probabilities and node utilities for probabil- 
ity trees representing alternative treatment strategies, a 
public domain software package that can be used for the 
construction, analysis and comparison of probability trees 
with random parameters was developed. To facilitate spec- 
ification of the random variables that arise in medical 
Quantifying Uncertainty in Decision Making 
Perhaps the dominant aspect of any diagnostic or thera- 
peutic decision is the uncertainty surrounding the decision. 
Uncertainty can manifest itself in many forms. Often a 
decision must be made when the relevant data are uncertain. 
Sometimes a decision is required when the fundamental 
biologic processes are not understood. A decision may be 
mandated even before all of the potential facts and related 
information are available. Uncertainty produces great anxi- 
ety for both the decision maker and the patient because it 
generally means that there is a chance of a bad outcome as 
well as a good one. Decisions are made to favor the chances 
of good outcomes, but even the best decision can result in a 
bad outcome. 
how data are related to the decision that must be made. 
Within medicine, the art and science of medical decision 
making perform a role analogous to the role of navigation 
within the field of aeronautics. Medical decision making 
shows how medical facts and medical processes bear on 
clinical decisions and, just as the acquisition of medical 
information is subject to scientific inquiry, so too is the usage 
of data in medical decision making subject to scientific 
inquiry and analysis. 
Basic assumptions. In this review, we examine the role of 
uncertainty in medical decision making and outline some 
quantitative approaches to handling uncertainty in this con- 
text. At the outset, we postulate the following, perhaps 
controversial, assumption: medical decision making is sub- 
ject to scientific (quantitative) inquiry and analysis. Most 
medical research focuses on the acquisition and analysis of 
data. In contrast, medical decision making concentrates on 
Another related assumption is that medical decisions can 
be synthesized through quantitative models. The keyword 
here is “synthesized.” We will confine our attention to those 
approaches that use synthesis. These are quantitative meth- 
ods-namely, mathematical, statistical and computer mod- 
els of medical decisions. 
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Role of uncertainty in clinical decision models. Given that 
these assumptions are accepted, we will direct this discus- 
sion to the theme that uncertainty is a central factor in 
medical decision making. Uncertainty clouds understanding 
of essential medical facts and how they are integrated. This 
phenomenon may be manifested in two different ways: 1) 
some numerical characteristics of medical procedures may 
be subject to random variation according to known proba- 
bility distributions; and 2) some nonrandom characteristics 
may simply be unknown so that there is disagreement or 
uncertainty among experts about the exact values of those 
characteristics. For example, the operative mortality rate for 
coronary artery bypass grafting is known to vary within a 
certain range of values, but the efficacy of angioplasty is 
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Table 1. Probability of Outcomes for Alternative Strategies of 
Care in Patients After Myocardial Infarction 
Fatal Nonfatal 
Event Event 
No 
Event 
Average 
Value 
Alternatives/Weight 0 0.5 1 
Standard medical care 0.08 0.15 0.77 0.845 
Treadmill testing 0.04 0.06 0.90 0.930 
Thallium scan 0.03 0.05 0.92 0.945 
Angiography 0.02 0.08 0.90 0.940 
unknown. Models of medical decisions must recognize and 
accommodate uncertainty, however it arises. Useful deci- 
sion models must validly represent significant sources of 
uncertainty; moreover, they must provide a means for 
handling these effects in their analysis. 
To understand the role of uncertainty in clinical decision 
models, we will review decision-modeling methodologies in 
terms of their ability to represent sources of uncertainty in a 
valid manner. Specifically, we will focus solely on those 
methods that make some attempt to incorporate risk and 
probabilities and will comment on the strengths and weak- 
nesses of existing methodologies for dealing with uncer- 
tainty. Some areas for further research will be suggested. 
The Matrix Model 
It is convenient to represent a medical decision problem 
in a simple decision matrix. For example, in Table 1, certain 
decision alternatives available to test and treat patients after 
myocardial infarction are considered. The rows indicate the 
decision alternatives. In this illustration, there are four 
decision alternatives-medical therapy only as well as three 
strategies that screen patients for operable disease using one 
of three initial screening tests (exercise electrocardiography, 
exercise thallium scintigraphy and coronary angiography). 
The columns denote the possible outcomes in terms of 
cardiac events within 6 months: a fatal cardiac event, a 
nonfatal event and no event. The (i, j) entry in the matrix 
represents the probability that the ith decision alternative 
will result in the jth-specific outcome. 
Choosing among strategies. Although this illustration is 
idealized, it does convey an important message about uncer- 
tainty in medicine. Different decisions can yield the same 
outcome, and one decision can yield a range of outcomes. If 
an alternative was to be chosen based solely on this data set, 
several approaches could be taken in selecting one. First, we 
could act to minimize the uncertainty of particular undesir- 
able outcomes or to maximize the likelihood of acceptable 
outcomes. For example, we could choose the alternative 
strategy that has the smallest chance of a fatal event (coro- 
nary cineangiography), or we might select the alternative 
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Figure 1. Distribution of outcomes for two alternative strategies 
having input variables represented as random variables. 
that has the greatest chance of no event (exercise thallium 
scintigraphy). 
A second basic approach to the selection problem (Table 
1) is based on “averaging” all of the outcomes within each 
alternative. By assigning numerical scores to the outcomes, 
we could choose the alternative that has the largest average 
or expected score. In this example, the weights are given in 
the top row and the overall averages for each alternative are 
presented in the last column. Exercise thallium scintigraphy 
has the highest expected value. 
In practice, we may be interested in both approaches and 
might prefer a more complete representation of the range of 
outcomes and their probabilities. Figure 1 illustrates the 
“distribution” of the outcomes for specific alternatives. The 
distribution characterizes the results of our choices, and we 
can now base our choice on considerations of distributional 
properties like the mean, the 5th percentile, the 95th percen- 
tile and so forth. For example, if our concern centers on 
minimizing fatal events, the behavior of the outcomes in the 
distribution tails becomes important. However, if typical 
outcomes are of greater concern, the focus may be on the 
central part of the distribution. In general, to make a fully 
informed decision, we need to have available a meaningful 
tractable characterization of the general notion of “distri- 
bution shape” for the group of possible outcomes associated 
with each alternative decision. 
Although the matrix model is conceptually helpful in 
describing the uncertainty faced by the decision maker, 
understanding the relation between an alternative decision 
and its corresponding group of possible outcomes is consid- 
erably more involved than simply assigning probabilities to 
those outcomes. We need a model of the uncertain sequence 
of events that lead from a decision to an outcome. 
Stochastic Modeling 
In the published medical decision-making reports, there 
are three prominent tools for the modeling of stochastic 
decision processes: probability trees (decision trees), Mar- 
kov chains and Monte Carlo simulation. We will examine 
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Figure 2. Simplified probability tree for the outcomes after coro- 
nary angiography (Cath) for patients after myocardial infarction. 
CABG = coronary artery bypass graft surgery. 
each in terms of its ability to accommodate uncertainty in 
-6 -3 0 3 6 
0 mean - located at -1.448 std. dew. = 2.392 
0 mode - Located at -3.000 skewness = 0.427 
a median - located at -1.734 kurtosis = 2.399 
-95% tolerance znterval (-5.141 to 3.573) 
medical decisions. Figure 3. Example of a probability distribution to represent an 
input parameter. 
Decision Trees 
Decision tree analysis is the simplest and most popular 
method of examining a decision problem (1). In published 
studies, the analysis generally involves the comparison of 
alternative patient management strategies. Each strategy is 
usually described by a probability tree that is composed of 
branching probabilities and node utilities. For example, 
Figure 2 depicts a simplified probability tree representing the 
use of angiography for treating a patient after myocardial 
infarction (a more complete analysis is found in reference 2). 
In this representation, we see that all possible sequences of 
events are described by the tree. The probabilities on the 
branches describe the chances of intermediate outcomes. At 
each node, some utility measure may accrue. This utility 
measure may be a cost, the likelihood of a cardiac event or 
some dimensionless unit reflecting the patient’s status. Each 
leaf of the tree represents a final outcome for the protocol. 
The tree model is clearly superior to the matrix model as a 
graphic representation of the relation between the angiogra- 
phy decision and its potential outcomes. However, the group 
of possible outcomes resulting from angiography is also 
more complex, and we require a method to “summarize” 
the final result in order to compare angiography with the 
other alternative decisions such as exercise electrocardiog- 
raphy. Traditionally, the approach has been to compute the 
average or expected value of each associated tree and to 
compare decision alternatives accordingly. 
Even though a probability tree provides a more faithful 
representation of the complexity of a given decision process, 
the validity of this representation is critically dependent on 
the accuracy of the data on which the tree is based. The 
branching probabilities and the node utilities are given by 
constants. However, most medical “facts” are not con- 
stants, and the variability in medical data is a major source of 
uncertainty in medicine. Almost all physical parameters are 
known to have a range of observable values. For example, 
the costs associated with hospitalization and the treatment of 
diseases will not be constant. Furthermore there may be 
some disagreement, even among experts, about the specific 
value of many of the probabilities associated with various 
medical outcomes. Therefore, to reflect the uncertainty in 
such data, the corresponding input parameters must be 
modeled as random variables with specific probability dis- 
tributions (Fig. 3). 
When input data are characterized as random variables, 
two important concerns are introduced. First, how should 
random variable inputs be specified or defined? Second, 
what impact does the use of random variables for modeling 
input parameters have on current stochastic modeling tech- 
niques? 
Obtaining random variables. Clinicians generally work in 
a “data-poor” environment-they are “long on insight, but 
short on numbers.” There is a tendency to resort to conve- 
nient assumptions such as assuming all random variables are 
normally distributed. However, such broad approximations 
of medical parameters can be misleading and possibly 
wrong. For example, most parameters in medicine are 
bounded, unlike the normal distribution, and many are 
distinctly nonnormal in their skewness and in other standard 
characteristics. Better alternative representations may be 
obtained with the triangular or beta distributions. However, 
in general, the choice among distributions to represent 
stochastic input parameters is complex, principally because 
of the overwhelming number of possible choices. 
In practice, the clinician is not concerned about the exact 
form of the underlying distribution; instead he simply seeks 
a representation that adequately captures the prominent 
features of existing data and clinical experience. One solu- 
tion to this problem is to use a flexible “system” of distri- 
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Figure 4. Probability tree using random variables to represent input 
probabilities and outcomes (shown as utilities). 
butions that facilitates the specification of relevant parame- 
ters using either sample data or expert opinion. We believe 
that this approach is preferable to the conventional fitting 
procedure that requires the user to select a distribution type 
from a miscellaneous collection of distributions in an arbi- 
trary ad hoc fashion. Our vehicle for implementing this 
approach is the Johnson translation system of probability 
Two public domain computer programs have been devel- 
oped to assist in the specification of a Johnson distribution 
distributions (3), which incorporates probability density 
(4). One provides specification based exclusively on data, 
and the other provides for subjective specification. The latter 
program employs the bounded Johnson system and is par- 
functions capable of representing a wide variety of basic 
ticularly useful when few or no data are available. This 
program graphically displays the distribution and permits 
shapes and which can match all feasible combinations of the 
interactive curve modification as well as the numeric speci- 
fication of desired distribution characteristics (5). The data- 
first four moments (that is, mean, variance, skewness and 
driven program can fit a Johnson distribution to any data set 
using a wide variety of statistical estimation procedures. 
kurtosis). 
Both programs run on microcomputers and are designed to 
be easy to use. We note that the so-called logistic normal 
distribution, recently proposed (6) as a good input model, is 
a special case of the bounded Johnson family. 
As a consequence of these developments, random vari- 
able inputs to decision models are now more easily obtained 
by clinicians, even in a data-poor environment. Further- 
more, the specification of a random variable can reflect 
clinical intuition as well as clinical observations. 
Probability trees in the presence of random variables. 
Using random variable inputs in the stochastic models for 
medical decisions creates significant methodologic prob- 
lems. For example, in the simple probability tree for the 
cineangiography strategy, the computation of standard sum- 
mary measures is greatly complicated when the input param- 
eters (namely, the branching probabilities and the utilities) 
are random variables (Fig. 4). There is no simple extension 
of the standard decision tree methods to directly accommo- 
date all of this uncertainty; moreover, there are alternative 
views as to how to summarize a probability tree composed of 
random variables. We, along with others (C&10), have ex- 
plored ways to approximate the distribution of outcome 
measures for probability trees with random variable param- 
eters. Our approach uses an Edgeworth expansion of the 
target distribution based on its first four moments. This 
technique may be viewed as a correction to the usual normal 
approximation that accounts for the skewness and kurtosis 
of the performance measure of interest. Furthermore, this 
approximation procedure exploits the special structure of 
probability trees to perform the necessary moment compu- 
tations in an efficient, numerically robust manner. 
Three important aspects of this work bear special empha- 
sis. First, trees representing medical decisions often have 
repetitive structures and similar subtrees. Such “repeti- 
tions” are more than a descriptive nuisance in a tree with 
random variable parameters because they represent dupli- 
cated random variables and not simply independent replica- 
tions from a common distribution. Duplicated random vari- 
ables are not independent pieces of data; rather, they 
represent identical pieces of information occurring at several 
locations in the tree. Although such a lack of independence 
greatly complicates the analysis, our methodology handles it 
explicitly. 
Second, we have extended our methodology to handle the 
pairwise comparison of probability trees when some or all of 
the compared trees contain random variable parameters 
(11). This development permits alternative decisions to be 
directly compared. In this situation, the outcome of interest 
is the difference between the performance measures pro- 
duced by each of the alternatives to be compared, and 
interest centers on estimating the distribution of this differ- 
ence. Thus, the selection of an alternative strategy can be 
based on the probability of observing a difference exceeding 
a prespecified threshold. The value of this technique is that 
all of the model uncertainty is directly and simultaneously 
represented in the distribution of the differences, a feature 
that other indirect means of reflecting uncertainty, such as 
sensitivity analysis, cannot provide. Furthermore, this new 
technology has been packaged within a public domain com- 
puter program that facilitates the construction, analysis and 
comparison of probability trees (11). 
Finally, there are two views of the overall summary 
measure of the probability tree. To date, most investigators 
have presented the distribution of the averaged-out value of 
a tree. In other words, they have attempted to describe what 
the expected value would be given a particular realization of 
the random parameters in the tree. This is a conditional 
expectation given the values of the tree parameters, and the 
direct medical or economic interpretation of such a condi- 
tional expectation is unclear. Instead, we propose a more 
clinically relevant measure that has an immediate interpre- 
tation. We propose to look directly at the individual patient’s 
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Figure 5. Markov transition diagram representing patient out- 
comes. Patients can survive with no event, experience a sudden 
fatal event or experience an event that is not suddenly fatal, but 
from which they might soon die. The transition probabilities govern 
the occurrence of these events. 
experience-that is, the utility accumulated by the patient in 
passing through the strategy (or sequence of activities) 
represented by the probability tree (12). The tree is summa- 
rized by conveniently characterizing the distribution of these 
individual experiences taken across patients. Alternative 
medical decisions can be based on the patient’s uncertainty 
rather than on the uncertainty in a statistical artifact. Also, 
patients can be conveniently grouped so that the decisions 
can be based on patient groupings. This grouping can be 
important for administrative, managerial and policy pur- 
poses. 
Figure 6. Network simulation model representing the clinical states 
in which a patient may be and the events that the patient may 
experience. CABG = coronary artery bypass graft surgery; CHF = 
congestive heart failure: MI = myocardial infarction. 
A central issue in the use of Markov chain models is the 
so-called lack of memory assumption, which may not be 
appropriate for many medical decision analyses. For exam- 
ple, in a Markov chain model of a patient with myocardial 
infarction, the probability of a future cardiac event must be 
independent of the patient’s previous condition or history. 
Clearly, this property is inappropriate in many cases, and it 
Markov Chains 
may preclude the use of such a model. It is possible to 
redefine various states of the Markov chain so that the 
A second stochastic modeling approach attempts to over- 
come an important deficiency of tree representations of 
medical decisions-namely, the fact that branches cannot be 
directed back to a previous node. For example, if the 
decision tree for cineangiography attempted to model the 
lifetime of the patient, rather than a relatively limited time 
horizon, the tree would grow enormously in size as we 
attempt to account for future possible cardiac events and 
their management over the aging of the patient. A better 
model would “cycle” patients among various health states, 
instead of considering each possible path for every possible 
patient. This approach is taken with Markov chain models. 
A simple Markov chain can be described by a transition 
diagram (Fig. 5). Such a diagram indicates the possible 
“destination” states to which a process can move from a 
given “origin” state. Again, these are given by probabilities. 
The encounter in each state may produce some “reward” 
given by a measure of outcome or utility. Most of the data 
are similar to that for a probability tree. Random variables 
can be incorporated in Markov chains only in the “reward” 
structure, and further research is needed to generalize the 
approach to include the use of random variables every- 
where. To automate the required computations, we also 
need efficient numeric algorithms implemented in portable, 
user-friendly software. 
relevant portion of the patient’s history is included in the 
specification of each state, but the resulting model can 
become unwieldy because of rapid proliferation in the num- 
ber of states required to describe the overall process, and 
numeric problems can occur in the computation of summary 
measures. 
Computer Simulation 
The third major technique being employed in modeling 
medical decisions is the computer-based Monte Carlo simu- 
lation. Rather than attempting to “solve” for summary 
measures analytically, simulation models describe the pro- 
cess. It is left to the computer to execute the process 
repeatedly, each time yielding a random sample of the 
summary measure. After many replications, an empiric 
distribution of the summary measure is presented. 
To illustrate this, in Figure 6 we depict a simple network 
structure based on the experience of all patients with myo- 
cardial infarction. In a manner similar to a transition diagram 
for a Markov chain, the various “origin” and “destination” 
states of a patient can be represented in a network diagram. 
However, the movement of patients among these states is 
not necessarily controlled by a set of fixed transition prob- 
abilities; instead, such movement can be governed by any 
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set of information. Furthermore, the intermediate and final 
outcomes are not limited to a single performance measure. 
Throughout the course of the simulation, random variables 
can be included in any specification. The simulation exe- 
cutes by bringing a patient into a network of interconnected 
nodes (13,14). Characteristics of the incoming patient are 
then determined, and some values may be sampled from 
statistical distributions. Subsequently, the patient moves 
among the nodes representing various states of health, aging 
and experiencing various cardiac events, tests and treat- 
ments. Eventually, the patient dies and his or her history is 
recorded. Many patients are simulated in this fashion to 
produce a sample large enough to draw statistically reliable 
conclusions about the process being studied. Different pa- 
tient management strategies may be examined and compared 
in this way. 
Modeling by network simulation is facilitated through use 
of the INSIGHT simulation language (15). INSIGHT is a 
high level language based on a graphic description of sys- 
tems. It uses stylized nodes to represent fundamental pro- 
cesses, and the branches connecting nodes represent the 
interrelations among the processes. The INSIGHT simula- 
tion system consists of a Modeler, which interactively con- 
structs a computer-readable representation of the procedure 
to be studied. The computer model can be executed inter- 
actively on various computers, from microcomputers to 
supercomputers. 
Conclusions 
Modeling is a uniquely clinical task. It should not be 
delegated or relegated as a routine mechanical exercise. A 
model encompasses both the objective information derived 
from clinical data as well as the subjective information based 
on clinical experience. Models that are purely data-driven 
will have severely limited applicability because they ignore 
clinical experience. 
Models are always approximations of reality. They do not 
constitute reality. A model simply represents the current 
state of knowledge about a decision. It is a growth asset to be 
examined and reexamined. It can never be the final truth. 
Models must be revised as new information becomes avail- 
able. 
Models are an important adjunct to clinical trials. Models 
should be developed routinely for clinical practice and used 
to identify arenas for clinical trials. A clinical trial cannot 
examine all possible combinations of tests and treatments, 
but clinical trials do provide the best evidence of effective- 
ness. 
Uncertainty is a central factor in medical decision mak- 
ing. Medical decisions are made in environments with un- 
certainty. Not only are the processes stochastic, but the 
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parameters describing these processes must also frequently 
be interpreted as random variables. Fortunately, the random 
variables can be identified and incorporated into the models. 
Of the modeling techniques available, simulation offers a 
truly general approach to the widest incorporation of uncer- 
tainty in a stochastic environment. In problems with more 
restricted ranges of uncertainty, other tools of stochastic 
analysis are useful. These and other modeling techniques 
offer fertile areas of future research. 
Finally, many of the tools for examining medical deci- 
sions are now available for investigation of clinical decision 
making. Clinicians do not need to be expert statisticians, 
mathematicians or engineers to use them. They are oriented 
to modelers, whose company should include many physi- 
cians. 
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